Tisagenlecleucel-T for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up to 25 years

^*Corresponding author for this work

Research output: Book/Report › Commissioned report

Original language	English
Publisher	National Institute for Health and Care Excellence
Commissioning body	National Institute for Health and Care Excellence
Publication status	Published - 21 Dec 2018

Access to Document

@book{0b77b191edc6415b83195b9a411c04f7,

title = "Tisagenlecleucel-T for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up to 25 years",

author = "Walton, {Matthew James} and Sahar Sharif and Lindsay Claxton and Kath Wright and Robert Hodgson and Simmonds, {Mark Crawford}",

year = "2018",

month = dec,

day = "21",

language = "English",

publisher = "National Institute for Health and Care Excellence",

}

TY - BOOK

T1 - Tisagenlecleucel-T for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up to 25 years

AU - Walton, Matthew James

AU - Sharif, Sahar

AU - Claxton, Lindsay

AU - Wright, Kath

AU - Hodgson, Robert

AU - Simmonds, Mark Crawford

PY - 2018/12/21

Y1 - 2018/12/21

M3 - Commissioned report

BT - Tisagenlecleucel-T for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up to 25 years

PB - National Institute for Health and Care Excellence

ER -